Oncoplastic breast conserving surgery (BCS) involves maintaining aesthetically natural breast contour while performing the radical resection of the tumor in patients with breast cancer (1-3). This principle could be adapted to all breast cancer patients except the ones requiring total mastectomy.
(n=2), inferior (n=6), lateral (n=4) and central (n=1) sections of the breast. Postoperative photographs and chart reviews were used to evaluate the results. Aesthetic satisfaction level survey was verbally obtained from the patients (0: Not satisfied, 1: Low, 2: Moderate, 3: High rate of satisfaction). All clinical parameters are presented in Table 1 .
Statistical analysis
Descriptive analysis was performed using GraphPad Prism software (GraphPad Software, Inc. La Jolla, CA 92037 USA).
Results
Bilateral oncoplastic breast reduction was performed on all patients except in one patient in whom one-sided reduction was conducted to preserve lactation (lateral pedicle). Nipple-areola complex was relocated to its new location on a chosen pedicle. The pedicle was selected according to the tumor location. In inferior location tumors superior pedicle, in lateral locations superomedial pedicle, in uppermedial locations superolateral pedicle was used. In one patient with a central localization, tumor nipple areola was not preserved. Especially tumors with the upper medial location were more challenging. Pedicle design was modified to obtain longer and a wider pedicle. Pedicle was anchored to the pectoral fascia to achieve fullness in the excised area (Figure 1-2 ).
In the postoperative follow-ups, one patient encountered wound healing problems after radiotherapy. After debridement, the wound closure was delayed for secondary healing. The complete closure of the wound was observed three weeks after the debridement. No other complications were seen in the other patients. 12 months after the surgery all the patients were tumor free and were aesthetically satisfied.
Discussion and Conclusions
We believe that this approach to BCS in patients with macromastia has many advantages. It improves the final aesthetic results by maintaining natural breast contours. This has been a problem with conventional BCS in recent decades (13) . Especially in large tumors maintaining the breast contour after resection has proven to be challenging. It has been reported in earlier studies that more than 15-20% reduction in the breast volume, depending on the tumor location, can decrease the aesthetic outcome of the surgery significantly (5, 17) . This volume was reported to be low as 5% for medial tumor locations (18) .
In our series all the patients were aesthetically satisfied. These patients were also relieved from their symptoms related to macromastia such as back and neck pains, which increased their overall satisfaction. Higher rate of patient satisfaction undergoing oncoplastic BCS was reported in earlier studies when compared to conventional BCS (11, 13, 19) . It was more challenging to achieve aesthetically pleasing results in tumors with central and upper medial locations as reported previously (3, 20) .
Another advantage of this approach to BCS is the increase in the surgical exposure during the tumor resection. We believe that the exposure and the resection of the tumor was much easier and wider excision was possible when compared to conventional BCS with the implementation of oncoplastic breast reduction. There is a risk of 4% contralateral second primary among the survivors of breast cancer (21) . Although not currently supported by the literature, we believe that risk of secondary primary might decrease with the oncoplastic BCS since the contralateral breast volume is reduced. We also believe that the efficiency of radiotherapy might increase after oncoplastic BCS since the total breast volume is decreased, but there are no studies up to date to support this idea.
In conclusion, we believe that oncoplastic BCS can achieve satisfactory results regarding the final aesthetic appearance and tumor control.
Further randomized controlled studies to compare oncoplastic BCS with conventional BCS are required to prove these findings.
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